Angel Porgador Selected Research

Natural Cytotoxicity Triggering Receptor 2

1/2019	Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA.
6/2007	Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angel Porgador Research Topics

Disease

42	Neoplasms (Cancer) 07/2022 - 01/2004
4	Infections 12/2018 - 10/2005
3	Head and Neck Neoplasms (Head and Neck Cancer) 05/2021 - 01/2019
3	Virus Diseases (Viral Diseases) 08/2019 - 02/2009
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2015 - 02/2010
3	Human Influenza (Influenza) 04/2010 - 01/2004
2	Carcinoma (Carcinomatosis) 07/2021 - 11/2008
2	Disease Progression 07/2021 - 05/2015
2	Melanoma (Melanoma, Malignant) 01/2021 - 04/2008
2	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 05/2015
2	Inflammation (Inflammations) 01/2017 - 02/2015
2	Fibrosarcoma 11/2010 - 04/2009
2	West Nile Fever 08/2010 - 02/2009
2	Tuberculosis (Tuberculoses) 10/2005 - 04/2002
1	Multiple Myeloma 04/2022
1	Hypoxia (Hypoxemia) 01/2022
1	COVID-19 11/2021
1	Malignant Mesothelioma 07/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2021
1	Adenocarcinoma of Lung 07/2021
1	Colitis 01/2021
1	Experimental Melanoma 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Cytokine Release Syndrome 01/2021
1	Rheumatoid Arthritis 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Squamous Cell Carcinoma of Head and Neck 10/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Obesity 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Leukemia 05/2015
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2015
1	Hypercholesterolemia 02/2015
1	Pneumococcal Infections 01/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2012
1	Adenocarcinoma 01/2011

Drug/Important Bio-Agent (IBA)

16	LigandsIBA 01/2019 - 01/2004
6	Proliferating Cell Nuclear Antigen (PCNA)IBA 04/2022 - 12/2011
6	Heparitin Sulfate (Heparan Sulfate)IBA 02/2009 - 08/2004
5	AntigensIBA 01/2021 - 09/2007
5	Peptides (Polypeptides)IBA 01/2018 - 11/2008
5	Natural Cytotoxicity Triggering Receptor 1IBA 01/2017 - 04/2002
4	Chimeric Antigen ReceptorsIBA 07/2022 - 01/2017
4	Protein Isoforms (Isoforms)IBA 05/2021 - 01/2017
4	Polysaccharides (Glycans)IBA 05/2015 - 01/2008
4	EpitopesIBA 08/2010 - 02/2005
4	Heparin (Liquaemin)FDA LinkGeneric 02/2009 - 11/2005
3	AntibodiesIBA 11/2021 - 02/2009
3	Pharmaceutical PreparationsIBA 01/2019 - 12/2014
3	Natural Killer Cell ReceptorsIBA 01/2019 - 05/2006
3	Immunoglobulin G (IgG)IBA 01/2017 - 05/2008
3	Proteins (Proteins, Gene)FDA Link 02/2010 - 06/2007
2	Monoclonal AntibodiesIBA 11/2021 - 12/2014
2	Immune Checkpoint InhibitorsIBA 07/2021 - 01/2020
2	Insulin (Novolin)FDA Link 05/2021 - 09/2011
2	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2015
2	Natural Cytotoxicity Triggering Receptor 2IBA 01/2019 - 06/2007
2	CytokinesIBA 12/2018 - 01/2017
2	LipidsIBA 01/2017 - 02/2015
2	Viral HemagglutininsIBA 04/2010 - 01/2004
2	Hemagglutinins (Hemagglutinin)IBA 04/2010 - 01/2004
2	antineoplaston A10 (A 10)IBA 02/2009 - 11/2005
2	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 06/2007 - 11/2005
1	ElementsIBA 01/2022
1	Neutralizing AntibodiesIBA 11/2021
1	pembrolizumabIBA 07/2021
1	lenvatinibIBA 07/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2021
1	Small Interfering RNA (siRNA)IBA 05/2021
1	Axitinib (AG 013736)IBA 04/2021
1	Everolimus FDA Link 04/2021
1	aldesleukin (Proleukin)FDA Link 01/2021
1	AlpelisibIBA 10/2020
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 10/2020
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 01/2020
1	purineIBA 01/2020
1	SolutionsIBA 01/2020
1	Circulating MicroRNAIBA 01/2020
1	VaccinesIBA 08/2019
1	Viral ProteinsIBA 08/2019
1	ParaffinIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	Cell-Penetrating PeptidesIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2017
1	Conditioned Culture MediaIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 10/2015
1	NK Cell Lectin-Like Receptor Subfamily KIBA 05/2015
1	Interleukin-15 (Interleukin 15)IBA 05/2015
1	Lipoproteins (Lipoprotein)IBA 02/2015
1	CholesterolIBA 02/2015
1	GTP-Binding Proteins (G-Protein)IBA 11/2014
1	Biomarkers (Surrogate Marker)IBA 01/2011

Therapy/Procedure

8	Therapeutics 01/2021 - 05/2008
3	Immunotherapy 01/2022 - 12/2014
1	Drug Therapy (Chemotherapy) 07/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Intravenous Administration 01/2019
1	Injections 09/2011
1	Islets of Langerhans Transplantation 09/2011